Outcomes with the Tandem Protek Duo Dual-Lumen Percutaneous Right Ventricular Assist Device.

Recently, a percutaneous right ventricular assist device (RVAD) called the TandemLife Protek Duo (TPD; TandemLife, Pittsburgh, PA) has been introduced. The Protek Duo (TPD) is a temporary RVAD placed via the right internal jugular vein, capable of providing up to 4.5 L of flow. We report a two-center experience using the TPD in 17 patients with right ventricular (RV) failure, 12 of whom were post-left ventricular assist device (LVAD) implantation.

[1]  W. O’Neill,et al.  Impella RP Post Approval Study: First Multi-Center, Prospective Post Market Approval Results for the Impella RP in Patients with Right Ventricular Failure , 2017 .

[2]  M. Scherer,et al.  Can Perioperative Right Ventricular Support Prevent Postoperative Right Heart Failure in Patients With Biventricular Dysfunction Undergoing Left Ventricular Assist Device Implantation? , 2016, Journal of cardiothoracic and vascular anesthesia.

[3]  Robert L Kormos,et al.  Seventh INTERMACS annual report: 15,000 patients and counting. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  J. Teuteberg,et al.  Right ventricular failure after left ventricular assist devices. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  N. Uriel,et al.  Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.